gdc

Cholangiocarcinoma

Biomarker Testing Crucial for Patients with Cholangiocarcinoma
BiomarkersCholangiocarcinomaGenetics & Cancer
New treatments are becoming available for patients with cholangiocarcinoma (bile duct cancer). Testing for specific biomarkers is crucial to ensure each patient receives the best available treatment for any associated biomarker.
Pemazyre First Therapy Approved for Cholangiocarcinoma with FGFR2 Biomarker
CholangiocarcinomaFDA Approvals, News & Updates
In April, the FDA approved Pemazyre, the first targeted drug for patients with advanced cholangiocarcinoma and a biomarker called FGFR2 gene fusion.
February Is Gallbladder and Bile Duct Cancer Awareness Month
CholangiocarcinomaSlideshowsWeb Exclusives
View this slideshow to learn important facts about Gallbladder and bile duct cancer, including statistics, causes and symptoms.
Mother of 6 and a Beacon of Hope for Others
Cholangiocarcinoma
The following section features a selection of patient stories submitted to the 2015 Hero of Hope Patient Award. These stories illustrate the range of extraordinary patient profiles submitted by patients, family members, friends, and healthcare providers.

Results 1 - 5 of 5

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country